2009
[Prev Page]
[
Next Page
]
Page 1 of 2
171 Messages
[
Date Index
]
[
Author Index
]
Regulatory Affairs
Seasons Greetings
,
A. D'Emanuele
[RegAffairs]Climatic zone
,
deepak jain
[RegAffairs]Re: Climatic zone
,
Malcolm Ross
<Possible follow-up(s)>
[RegAffairs]Re: Climatic zone
,
Richard P Poska
[RegAffairs]Re: Climatic zone
,
Surender Kumar
[RegAffairs]Re: Climatic zone
,
PharmWeb
[RegAffairs]Re: Climatic zone
,
Brian MATTHEWS
[RegAffairs]Re: Climatic zone
,
Malcolm Ross
[RegAffairs]BE report No of CRF
,
PAKHI RUSIA
[RegAffairs]Cosmetovigilance Report
,
Luv Wadhwani
[RegAffairs]Re: Cosmetovigilance Report
,
Muthiah Saravanan
<Possible follow-up(s)>
[RegAffairs]Re: Cosmetovigilance Report
,
Lassoff, Peter
[RegAffairs]Regulatory guidelines
,
Brijesh Yadav
[RegAffairs]DMF Annual Reports
,
Globepharm /Consulting
[RegAffairs]RE: DMF Annual Reports
,
Ketan Agravat
[RegAffairs]Excipient clarity
,
prasanna sagar
[RegAffairs]Regulatory Affairs Certificate vs. Master of Sciencein RA
,
Luke
[RegAffairs]Site registration in Japan
,
ivan piccoli
[RegAffairs]Re: Site registration in Japan
,
Brian MATTHEWS
<Possible follow-up(s)>
[RegAffairs]Re: site registration in Japan
,
shakeel.salam
[RegAffairs]Re: Site registration in Japan
,
Surender Kamal
[RegAffairs]Re: BE report no of CRF
,
shakeel
[RegAffairs]USP versus in-house API specification
,
Kams
[RegAffairs]RE: USP versus in-house API specification
,
Ketan Agravat
<Possible follow-up(s)>
[RegAffairs]Re: USP versus in-house API specification
,
Brian MATTHEWS
[RegAffairs]Re: USP versus in-house API specification
,
Malcolm Ross
[RegAffairs]Biowaiver for Iron Containing Product
,
Surender Kamal
[RegAffairs]Query on stability studies
,
Luv Wadhwani
[RegAffairs]API % Assay Calculation in Commercial Batch
,
Anand G
[RegAffairs]Re: Query on stability studies
,
Brian MATTHEWS
<Possible follow-up(s)>
[RegAffairs]Re: Query on stability studies
,
Malcolm Ross
[RegAffairs]Re: Query on stability studies
,
Surender Kamal
[RegAffairs]Re: Query on stability studies
,
aks
[RegAffairs]Re: Query on stability studies
,
ge guo
[RegAffairs]Re: Query on stability studies
,
Ranjith Gamage
[RegAffairs]Re: API % Assay Calculation in Commercial Batch
,
Surender Kamal
<Possible follow-up(s)>
[RegAffairs]Re: API % Assay Calculation in Commercial Batch
,
Ranjith Gamage
[RegAffairs]Re: API % Assay Calculation in Commercial Batch
,
Frank W
[RegAffairs]Query on Microbiological Testing of Non-Sterile Drugproducts; Oral Solid Dosage Forms
,
virgilio jun v villanueva
[RegAffairs]Re: Query on Microbiological Testing of Non-SterileDrug products; Oral Solid Dosage Forms
,
Surender Kamal
<Possible follow-up(s)>
[RegAffairs]Re: Query on Microbiological Testing of Non-SterileDrug products; Oral Solid Dosage Forms
,
Meena Shah
[RegAffairs]US requirements for plastic bags intended for storageof APIs
,
ybobinnec
[RegAffairs]Re: US requirements for plastic bags intended forstorage of APIs
,
Surender Kamal
[RegAffairs]Microbiology limit
,
Sunil Durge
[RegAffairs]Re: Microbiology limit
,
Brijesh Yadav
[RegAffairs]Reg Registration requirements in Brazil and Argentina
,
Ashish Meher \(SRS\)
[RegAffairs]Re: Reg Registration requirements in Brazil andArgentina
,
Surender Kamal
[RegAffairs]Listing of regulatory bodies
,
Paul O'Hagan
[RegAffairs]U.S. FDA guidelines for Label and Package inserts
,
Luv Wadhwani
[RegAffairs]Re: U.S. FDA guidelines for Label and Package inserts
,
ge guo
<Possible follow-up(s)>
[RegAffairs]RE: U.S. FDA guidelines for Label and Package inserts
,
Sreejith Kurup
[RegAffairs]RE: U.S. FDA guidelines for Label and Package inserts
,
KIRAN
[RegAffairs]RE: Listing of regulatory bodies
,
r ramesh
<Possible follow-up(s)>
[RegAffairs]Re: Listing of regulatory bodies
,
Surender Kamal
[RegAffairs]RE: Listing of regulatory bodies
,
Sreejith Kurup
[RegAffairs]SPL for package insert in original ANDA
,
kiran
[RegAffairs]PET Testing
,
Virender Kumar
[RegAffairs]Re: PET Testing
,
Brijesh Yadav
<Possible follow-up(s)>
[RegAffairs]Re: PET testing
,
Luv Wadhwani
[RegAffairs]Re: PET testing
,
Brian MATTHEWS
[RegAffairs]Re: PET Testing
,
Surender Kamal
[RegAffairs]Re: PET Testing
,
Brian MATTHEWS
[RegAffairs]Re: PET testing
,
Steve Binysh
[RegAffairs]Reduce testing frequencies for real time stabilitystudies
,
Dasari Srinivasa Rao
[RegAffairs]Re: Reduce testing frequencies for real timestability studies
,
Brian MATTHEWS
[RegAffairs]Compliance with specification at the end of shelf life
,
yves.bobinnec
[RegAffairs]Re: Compliance with specification at the end of shelflife
,
Tudorache Luminita
<Possible follow-up(s)>
[RegAffairs]Re: Compliance with specification at the end of shelflife
,
Brian MATTHEWS
[RegAffairs]Re: Compliance with specification at the end of shelflife
,
Surender Kamal
[RegAffairs]Re: Compliance with specification at the end of shelflife
,
ge guo
[RegAffairs]Re: Compliance with specification at the end of shelflife
,
AMIT JAIN
[RegAffairs]Re: Compliance with specification at the end of shelflife
,
Muthiah Saravanan
[RegAffairs]RE: Compliance with specification at the end of shelflife
,
Meena Shah
[RegAffairs]Re: Compliance with specification at the end ofshelflife
,
Luv Wadhwani
<Possible follow-up(s)>
[RegAffairs]Re: Compliance with specification at the end ofshelflife
,
Brian MATTHEWS
[RegAffairs]Accommodating multiple indications on Product Insert(PIL)
,
Anne Casey
[RegAffairs]Re: Accommodating multiple indications on ProductInsert (PIL)
,
Brian MATTHEWS
[RegAffairs]Stability studies of products with Large Pack Size
,
Luv Wadhwani
[RegAffairs]Re: Stability studies of products with Large Pack Size
,
akkineni lakshmi
<Possible follow-up(s)>
[RegAffairs]Re: Stability studies of products with Large Pack Size
,
lt09
[RegAffairs]Re: Stability studies of products with Large Pack Size
,
ge guo
[RegAffairs]Re: Stability studies of products with Large Pack Size
,
Ranjith Gamage
[RegAffairs]CTD Romania query
,
Brijesh Yadav
[RegAffairs]Re: CTD Romania query
,
Tudorache Luminita
<Possible follow-up(s)>
[RegAffairs]Re: CTD Romania query
,
KIRAN
[RegAffairs]Re: CTD Romania query
,
akkineni lakshmi
[RegAffairs]ANDA Section
,
HETAL PATEL
[RegAffairs]Re: ANDA Section
,
shaikim
<Possible follow-up(s)>
[RegAffairs]RE: ANDA Section
,
Meena Shah
[RegAffairs]RE: ANDA Section
,
K. Harikishan
[RegAffairs]RE: ANDA Section
,
KIRAN
[RegAffairs]Re: ANDA Section
,
shakeel
[RegAffairs]Residual Solvent
,
Ashok Suthar
<Possible follow-up(s)>
[RegAffairs]Residual Solvent
,
Ashok Suthar
[RegAffairs]Relaxation of LOD limit at granulation stage
,
piyush
[RegAffairs]RE: Residual Solvent
,
KIRAN
<Possible follow-up(s)>
[RegAffairs]Re: Residual Solvent
,
Surender Kamal
[RegAffairs]Re: Residual Solvent
,
Virender Kumar
[RegAffairs]Re: Relaxation of LOD limit at granulation stage
,
Richard P Poska
[RegAffairs]Requirements for clinical supply to Japan
,
Anne Casey
[Prev Page]
[
Next Page
]
Page 1 of 2
171 Messages
[
Date Index
]
[
Author Index
]
Mail converted by
MHonArc
2.3.3